U.S. markets close in 46 minutes

Constellation Pharmaceuticals, Inc. (CNST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.11+0.30 (+1.29%)
As of 3:12PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
100,678
86,055
61,244
39,088
33,658
Operating Income
-100,678
-86,055
-61,244
-39,088
-33,658
Net Non Operating Interest Income Expense
158
529
1,319
-732
-1,292
Other Income Expense
-
-
-
4,443
417
Pretax Income
-100,491
-85,526
-59,925
-35,377
-34,533
Tax Provision
63
24
-
-
-
Net Income Common Stockholders
-100,554
-85,550
-59,925
-39,792
-49,465
Diluted NI Available to Com Stockholders
-100,554
-85,550
-59,925
-39,792
-49,465
Basic EPS
-
-0.003
-0.005
-0.0034
-0.0455
Diluted EPS
-
-0.003
-0.005
-0.0034
-0.0455
Basic Average Shares
-
28,152
11,984
11,690
1,087
Diluted Average Shares
-
28,152
11,984
11,690
1,087
Total Operating Income as Reported
-100,678
-86,055
-61,244
-39,088
-33,658
Total Expenses
100,678
86,055
61,244
39,088
33,658
Net Income from Continuing & Discontinued Operation
-100,554
-85,550
-59,925
-35,377
-34,533
Normalized Income
-100,554
-85,550
-59,925
-35,377
-34,533
Interest Income
3,327
2,644
1,547
169
53
Interest Expense
3,169
2,115
228
901
1,345
Net Interest Income
158
529
1,319
-732
-1,292
EBIT
-97,322
-83,411
-59,697
-34,476
-33,188
EBITDA
-96,661
-
-
-
-
Reconciled Depreciation
661
758
562
474
203
Net Income from Continuing Operation Net Minority Interest
-100,554
-85,550
-59,925
-35,377
-34,533
Normalized EBITDA
-96,661
-82,653
-59,135
-34,002
-32,985
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0